Sign in

CIK 0001517022

  • Large accelerated filer

Akebia Therapeutics, Inc.

Sign in to watch
Ticker
AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208756903
Phone
+1 617-871-2098
Business address
180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
  1. 4 Grant or award SVP, Chief Accounting Officer acquired 79,000 shares (grant or award)
  2. 4 Grant or award SVP, CFO, CBO & Treasurer acquired 204,000 shares (grant or award)
  3. 4 Grant or award CEO and President acquired 743,000 shares (grant or award)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Planned sale SVP, CFO, CBO & Treasurer sold 41,314 shares at $3.67 ($151,622)
  6. 4 Grant or award Director acquired 35,700 shares (grant or award)
  7. 4 Grant or award Director acquired 35,700 shares (grant or award)
  8. 4 Grant or award Director acquired 35,700 shares (grant or award)
  9. 4 Grant or award Director acquired 35,700 shares (grant or award)
  10. 4 Grant or award Director acquired 35,700 shares (grant or award)
  11. 4 Grant or award Director acquired 35,700 shares (grant or award)
  12. 4 Grant or award Director acquired 35,700 shares (grant or award)
  13. 4 Planned sale SVP, Chief Accounting Officer sold 15,000 shares at $4.01 ($60,150)
  14. 4 Planned sale SVP, Chief Accounting Officer sold 13,334 shares at $3.53 ($47,069)
  15. 4 Planned sale CEO and President sold 46,409 shares at $1.83 ($84,928)
  16. 4 Planned sale SVP, Chief Medical Officer sold 7,144 shares at $1.83 ($13,074)
  17. 4 Planned sale CEO and President sold 144,250 shares at $2.10 ($302,925)
  18. 4 Planned sale SVP, Chief Medical Officer sold 50,506 shares at $2.10 ($106,063)
  19. 4 Planned sale SVP, Chief Accounting Officer sold 30,202 shares at $2.10 ($63,424)
  20. 4 Planned sale Chief Commercial Officer sold 55,621 shares at $2.10 ($116,804)

Page 2 of 19 · 378 filings